HE
Health X Platform Ltd (HEALTHX)
₹275.60
Mkt cap
₹869 Cr
P/E ratio
—
P/B
1.38
Div yield
0.00%
ROE
0.44%
ROCE
0.03%
EPS (TTM)
—
Book value
₹199
52W range
253–363
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services [1]
NSE HEALTHXBSE 533259
Health check
Cautious
ProfitabilityWeak
GrowthHigh
TechnicalsBearish
52-week range
−24.08% from high₹276
₹253+9.15% from low₹363
Current
₹275.60
Prev close
₹272.50
Day
+1.14%
Price performance
1D
+0.92%
1W
+0.64%
1M
+2.29%
3M
−9.06%
6M
−3.42%
1Y
−3.76%
YTD
−12.72%
Financials
Revenue, profit & margin
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 358 | 374 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 | 484 | |
| YoY Sales growth | +41% | +33% | -2% | -20% | -24% | -25% | -7% | +10% | +10% | +23% | +31% | +50% | +61% | |
| Expenses | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 | 399 | 455 | 506 | |
| Operating Profit | 3 | 3 | -11 | -2 | -5 | -24 | -25 | 6 | -23 | -10 | -25 | -8 | -22 | |
| OPM % | 0.9% | 0.9% | -3.5% | -0.9% | -1.7% | -8% | -9% | 2.0% | -8% | -3.0% | -7% | -1.9% | -4.6% | |
| Other Income | 10 | 20 | 18 | 29 | -167 | -14 | 22 | 25 | 5 | 14 | 13 | 13 | 10 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Depreciation | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | |
| Profit before tax | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 | -19 | 1 | -15 | 2 | -15 | |
| Tax % | -23% | 4% | -583% | -103% | -13% | 2% | -478% | 12% | -17% | 60% | -12% | -1% | -16% | |
| Net Profit | -12 | -3 | 22 | 41 | -155 | -38 | 18 | 27 | -15 | 0 | -13 | 2 | -13 | |
| EPS in Rs | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.30 | 7.52 | -3.99 | 0.36 | -3.51 | 0.80 | -3.47 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −1.13% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 7 Aug '26◦ |
| Earnings day | −1.13% |
| +1 day | −1.83% |
| +5 days | −4.94% |
| +15 days | −1.71% |
| +30 days | −5.63% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202674.07%Promoter
Promoters74.07%
FIIs2.32%0.03
DIIs2.61%
Public20.98%0.04
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | ₹1,980.20 | 54.89 | 33,237 | 0.71% | 194 | +28.75% | 874 | +19.61% | 28.00% |
| Vijaya Diagnost. | ₹1,467.40 | 74.20 | 15,114 | 0.14% | 59 | +37.41% | 255 | +26.71% | 20.53% |
| Metropolis Healt | ₹567.00 | 50.98 | 11,767 | 0.35% | 75 | +43.04% | 497 | +15.76% | 17.81% |
| Thyrocare Tech. | ₹506.95 | 46.11 | 8,079 | 1.84% | 15 | −11.56% | 271 | +25.07% | 35.38% |
| Nephrocare Health Services | ₹667.75 | 52.41 | 6,715 | 0.00% | 34 | +454.07% | 303 | +23.47% | 15.34% |
| Suraksha Diagno. | ₹353.50 | 44.02 | 1,841 | 0.14% | 15 | +66.96% | 99 | +25.84% | 17.29% |
| Krsnaa Diagnost. | ₹518.70 | 16.66 | 1,683 | 0.39% | 25 | +8.95% | 240 | +31.17% | 12.71% |
| Health X Platform | ₹273.20 | — | 869 | 0.00% | −13 | +12.09% | 484 | +60.66% | 0.03% |
| Median: 16 Co. | ₹369.15 | 38.04 | 1,013 | 0.07% | 15 | +10.52% | 83 | +24.27% | 21.66% |
Filings
Annual reports15
Concall transcripts45
PPTNov 2026RECNov 2026TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026RECJun 2026PPTJun 2026TranscriptFeb 2026PPTFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025PPTAug 2025TranscriptJun 2025PPTJun 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024PPTOct 2024PPTJun 2024TranscriptFeb 2024PPTFeb 2024
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Nov - Q2 FY27 earnings conference call audio recording shared on 16 November 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Nov - Please find attached the Newspaper publication of unaudited financial results for the quarter and half year ended 30th September, 2026Announcement under Regulation 30 (LODR)-Investor Presentation 14 Nov - Please find attached the Investor Presentation.Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026 14 NovBoard Meeting Outcome for Outcome Of Board Meeting Held On 14Th November, 2026 14 Nov - Board approved Q2 and H1 FY2026 standalone and consolidated unaudited results on 14 Nov 2026.



